Tulsi Gabbard, President Donald Trump's pick to be director of national intelligence, faced sharp criticism from Democrats and Republicans alike Thursday during a fiery confirmation hearing.
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.